Clinical Data From the Systane® iLux2®System After 1 Year

Show Description +

Preeya K. Gupta, MD, highlights 1-year data of patient outcomes after starting treatment with the Systane® iLux2® Thermal Pulsation System (Alcon). Douglas K. Devries, OD, emphasizes that this system is effective, safe, and maintains positive outcomes for patients.

Posted: 1/28/2022

Up Next

Advanced Features of the Systane® iLux2® System

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD


First-Line Treatment for Meibomian Gland Dysfunction

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Improve Meibomian Gland Function and Tear Film Stability With Systane® iLux2®

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

What Makes the Systane® iLux2® Different From Traditional Heat Therapy?

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Clinical Data From the Systane® iLux2® System

Marguerite B. McDonald, MD, FACS; Preeya K. Gupta, MD; and Douglas K. Devries, OD

Clinical Data From the Systane® iLux2®System After 1 Year

Preeya K. Gupta, MD, highlights 1-year data of patient outcomes after starting treatment with the Systane® iLux2® Thermal Pulsation System (Alcon). Douglas K. Devries, OD, emphasizes that this system is effective, safe, and maintains positive outcomes for patients.

Posted: 1/28/2022

Resources

Perspectives On Prevalence, Gaps, and Management of MGD

View Resource

About Alcon

Visit us online: ilux.myalcon.com

IMPORTANT PRODUCT INFORMATION

Indication: The Systane® iLux is indicated for the application of localized heat and pressure therapy in adult patients with meibomian gland dysfunction (MGD), which is associated with evaporative dry eye, and to capture/store digital images and video of the meibomian glands.

Contraindications:

Do NOT use the Systane® iLux in patients with the following conditions: Patients whose pupils have been pharmaceutically dilated; patients with ocular injury or trauma, chemical burns, or limbal stem cell deficiency (within prior 3 months); patients with active ocular herpes zoster or simplex of eye or eyelid or a history of these within prior 3 months; patients with cicatricial lid margin disease; patients with active ocular infection, active ocular inflammation or history of chronic, recurrent ocular inflammation within prior 3 months; patients with an ocular surface abnormality that may compromise corneal integrity; patients with lid surface abnormalities that affect lid function in either eye; patients with aphakia; or patients with permanent makeup or tattoos on their eyelids.

Warnings/Precautions:

Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.

The Disposable may not fit all eyes, such as eyes with small palpebral fornices. Use of the Systane® iLux is NOT recommended in patients with the following conditions: moderate to severe allergic, vernal or giant papillary conjunctivitis; severe eyelid inflammation; systemic disease conditions that cause dry eye; in patients who are taking medications known to cause dryness; patients with punctal plugs, or patients who have undergone ocular surgery within prior 3 months.

Potential Adverse Reactions:

Potential adverse effects may occur because of the procedure. These effects include but are not limited to, the onset or increase in: eyelid/eye pain requiring discontinuation of the treatment procedure, eyelid irritation or inflammation, temporary reddening of the skin, ocular surface irritation or inflammation (e.g., corneal abrasion, conjunctival edema or conjunctival injection (hyperemia)), and ocular symptoms (e.g., burning, stinging, tearing, itching, discharge, redness, foreign body sensation, visual disturbance, sensitivity to light).

Attention: Please refer to the User Manual for a complete list of contraindications, instructions for use, warnings and precautions for the Systane® iLux.